跳至主要内容
临床试验/EUCTR2012-004368-23-DK
EUCTR2012-004368-23-DK进行中(未招募)不适用

Feasible strategy for preventing blood clots in critically ill patients with acute kidney Injury - F.B.I.

Odense University Hospital0 个研究点开始时间: 2012年10月25日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients who develop acute kidney injury, and who need CRRT
  • Weight 45 - 150 kg
  • Age =18 years
  • Informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 186

排除标准

  • Major trauma
  • Need for therapeutic anticoagulation
  • Contraindication to heparin(allergy, HIT)
  • Life-support limitation
  • Uncontrolled hypertension(bp > 180/110) i =12 timer
  • Cerebral haemorrhage , acute gastrointestinal bleeding
  • Severe thrombocytopenia (platelet count <50 × 109/l)
  • International Normalized Ratio or activated partial thromboplastin time =2 times the upper limit of normal
  • Chronic renal failure, or acute-on-chronic

研究者

相似试验